Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pandion Therapeutics (PAND)
NASDAQ:PAND
Holding PAND?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 23, 2020 | Becker Daniel J. Director | xxxxxxxxxxxxx | |
| Nov 19, 2020 | Becker Daniel J. Director | xxxxxxxxxxxxx | |
| Jul 23, 2020 | Roche Holding Ltd >10% Owner | xxxxxxxxxxxxx | |
| Jul 23, 2020 | Mutz Mitchell Director,>10% Owner | xxxxxxxxxxxxx |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Pandion Therapeutics (PAND)?
Currently, no data Available
What percentage of Pandion Therapeutics (PAND) stock is held by institutional investors?
Currently, no data Available
What percentage of Pandion Therapeutics (PAND) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Pandion Therapeutics (PAND)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.